首页 > 抗体蛋白 > 抗体
PE anti-mouse CD4 Antibody
产品名称:
PE anti-mouse CD4 Antibody
产品类别:
抗体
产品编号:
100407
产品应用:
100407
[价格]
规格 价格 库存
50µg ¥ 300 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation.?Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin < 0.01 EU/?g).

Application References

(PubMed link indicates BioLegend citation)
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  13. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  2. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  3. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  4. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  5. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  6. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  7. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  8. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  9. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  10. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  11. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  12. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  13. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  14. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  15. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  16. Willinger T, et al. 2014. J Exp Med. 211:685. PubMed
  17. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  18. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  19. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  20. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  21. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  22. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  23. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  24. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  25. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  26. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  27. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  28. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  29. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  30. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  31. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  32. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  33. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  34. Chen S et al. 2018. Cell reports. 25(7):1729-1740 . PubMed
  35. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  36. Yuan X, et al. 2019. JCI Insight. 4:e124317. PubMed
  37. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  38. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  39. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  40. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  41. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  42. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  43. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  44. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  45. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  46. Guo H, et al. 2022. PLoS Pathog. 18:e1010857. PubMed
  47. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  48. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  49. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  50. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  51. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  52. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  53. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  54. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  55. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  56. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  57. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  58. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  59. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  60. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  61. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  62. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  63. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  64. Lv F, et al. 2022. iScience. 25:103639. PubMed
  65. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  66. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  67. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  68. H?nes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  69. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  70. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  71. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  72. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  73. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  74. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  75. Yang H, et al. 2022. Nutrients. 14:. PubMed
  76. Yang C, et al. 2013. Proc Natl Acad Sci U S A. 111:109. PubMed
  77. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  78. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  79. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  80. Bai C, et al. 2020. Mol Ther Oncolytics. 17:9. PubMed
  81. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  82. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  83. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  84. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  85. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  86. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  87. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  88. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  89. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  90. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  91. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  92. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  93. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  94. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  95. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  96. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  97. Matsuo K, et al. 2018. J Immunol. 200:800. PubMed
  98. Du J, et al. 2018. AMB Express. 8:158. PubMed
  99. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  100. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  101. Cho K, et al. 2021. iScience. 24:103117. PubMed
  102. Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed
  103. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  104. Liyanage S, et al. 2016. Exp Eye Res. 151:160-70. PubMed
  105. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  106. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  107. Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
  108. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  109. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  110. Nakamura Y, et al. 2015. Infect Immun . 83:671. PubMed
  111. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  112. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  113. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  114. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  115. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  116. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  117. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  118. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  119. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  120. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  121. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  122. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  123. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  124. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  125. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  126. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  127. Zhang H, et al. 2009. Invest Ophthalmol Vis Sci. 50:2653. PubMed
  128. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  129. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  130. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  131. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  132. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  133. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  134. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  135. Chen S, et al. 2022. iScience. 25:105176. PubMed
  136. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  137. Mahlios J, Zhuang Y 2011. Mol Immunol. 49:227. PubMed
  138. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  139. Klose R, et al. 2016. Nat Commun. 7:12528. PubMed
  140. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  141. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  142. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  143. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  144. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  145. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  146. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  147. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  148. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  149. Yomogida K, et al. 2013. Biochem Biophys Res Commun. 434:263. PubMed
  150. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  151. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  152. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  153. Li H, et al. 2022. iScience. 25:104481. PubMed
  154. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  155. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  156. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  157. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  158. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  159. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  160. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  161. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  162. Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed
  163. Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
  164. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  165. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  166. Gawish R, et al. 2022. Elife. 11:. PubMed
  167. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  168. Sun J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:15:00. PubMed
  169. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  170. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  171. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  172. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  173. Lee S, et al. 2021. Autophagy. Online ahead of print. PubMed
  174. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  175. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  176. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
RRID
AB_312692 (BioLegend Cat. No. 100407) AB_312693 (BioLegend Cat. No. 100408)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线